BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6135171)

  • 1. Ultrastructural evidence for endogenous somatostatin-like immunoreactivity in the pituitary gland.
    Morel G; Mesguich P; Dubois MP; Dubois PM
    Neuroendocrinology; 1983; 36(4):291-9. PubMed ID: 6135171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural evidence for endogenous substance-P-like immunoreactivity in the rat pituitary gland.
    Morel G; Chayvialle JA; Kerdelhue B; Dubois PM
    Neuroendocrinology; 1982; 35(2):86-92. PubMed ID: 6182500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland.
    Morel G; Besson J; Rosselin G; Dubois PM
    Neuroendocrinology; 1982 Feb; 34(2):85-9. PubMed ID: 7070588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-28- and somatostatin-14-like immunoreactivities in the rat pituitary gland.
    Mesguich P; Benoit R; Dubois PM; Morel G
    Cell Tissue Res; 1988 May; 252(2):419-27. PubMed ID: 2898294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of angiotensin II in the adult male rat anterior pituitary gland: immunocytochemical study after cryoultramicrotomy.
    Chabot JG; Gray DA; Dubois PM; Morel G
    Exp Cell Res; 1989 Jan; 180(1):189-97. PubMed ID: 2642425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a direct action of neuropeptide Y in the rat pituitary gland.
    Chabot JG; Enjalbert A; Pelletier G; Dubois PM; Morel G
    Neuroendocrinology; 1988 Jun; 47(6):511-7. PubMed ID: 3399034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.
    Shirasu K; Stumpf WE; Sar M
    Endocrinology; 1990 Jul; 127(1):344-9. PubMed ID: 1972921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunoenzymatic localization of prolactin and growth hormone in human and rat pituitaries.
    Martin-Comin J; Robyn C
    J Histochem Cytochem; 1976 Sep; 24(9):1012-6. PubMed ID: 61240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
    Kentroti S; Aguila MC; McCann SM
    Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural evidence for oxytocin in the rat anterior pituitary gland.
    Morel G; Chabot JG; Dubois PM
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):307-14. PubMed ID: 3289299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural colocalization of growth hormone binding protein and pituitary hormones in adenohypophyseal cells of the rat.
    Harvey S; Baumbach WR; Sadeghi H; Sanders EJ
    Endocrinology; 1993 Sep; 133(3):1125-30. PubMed ID: 8396011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of thyrotropin-releasing hormone (TRH)- and neuropeptide Y (NPY)-like immunoreactivity in the neurointermediate lobe of the frog pituitary.
    Morel G; Leneveu E; Tonon MC; Pelletier G; Vaudry H; Dubois PM
    Peptides; 1985; 6(6):1085-91. PubMed ID: 3938839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary somatostatin receptor (sst)1-5 expression during rat development: age-dependent expression of sst2.
    Reed DK; Korytko AI; Hipkin RW; Wehrenberg WB; Schonbrunn A; Cuttler L
    Endocrinology; 1999 Oct; 140(10):4739-44. PubMed ID: 10499533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.
    Schonbrunn A; Rorstad OP; Westendorf JM; Martin JB
    Endocrinology; 1983 Nov; 113(5):1559-67. PubMed ID: 6138246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural evidence for endogenous growth hormone-releasing factor-like immunoreactivity in the monkey pituitary gland.
    Morel G; Mesguich P; Dubois MP; Dubois PM
    Neuroendocrinology; 1984 Feb; 38(2):123-33. PubMed ID: 6425708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural characterization of neurosecretory fibres immunoreactive for vasotocin, isotocin, somatostatin, LHRH and CRF in the pituitary of a teleost fish, Poecilia latipinna.
    Batten TF
    Cell Tissue Res; 1986; 244(3):661-72. PubMed ID: 2872964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone receptor binding protein in rat anterior pituitary.
    Mertani HC; Waters MJ; Jambou R; Gossard F; Morel G
    Neuroendocrinology; 1994 May; 59(5):483-94. PubMed ID: 8022524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-containing neuron systems in the rat hypothalamus: retrograde tracing and immunohistochemical studies.
    Kawano H; Daikoku S
    J Comp Neurol; 1988 May; 271(2):293-9. PubMed ID: 2897982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I.
    Uchiyama T; Kaji H; Abe H; Chihara K
    Neuroendocrinology; 1994 May; 59(5):441-50. PubMed ID: 7912818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.